CMS recommends additional payment for using Shockwave’s IVL technology in hospital setting

Michael Walter | | Cardiovascular Business | Economics
Intravascular lithotripsy (IVL) therapy to break up calcified coronary lesions will now be reimbursed at a higher rate under new in-hospital codes the went into effect Oct. 1. Illustration of the Shockwave lithoplasty procedure using sonic waves to bust calcium without trauma.

CMS has ruled that coronary intravascular lithotripsy (IVL) cases performed in a hospital setting be eligible for an additional payment through a New Technology Add-On Payment (NTAP).

The proposal is included in the Fiscal Year 2022 Hospital Inpatient Prospective Payment System (IPPS) proposed rule, which was published April 27 and is currently open for public comment.

Shockwave Medical, the healthcare technology company that started developing IVL back I 2009, issued a statement in support of the recommendation.

“We applaud CMS for proposing an NTAP for Shockwave’s coronary IVL and for their commitment to improving Medicare beneficiary access to breakthrough technologies,” Robert Fletcher, vice president of marketing and market access for Shockwave Medical, said in a prepared statement. “This is another step forward in our early introduction of coronary IVL and in our mission to expand access to new technology that addresses a significant unmet need in the treatment of complex coronary artery disease.”

Shockwave’s IVL technology has gained FDA approval for the treatment of severely calcified coronary artery disease and peripheral arterial disease.

Click here to read more about IVL in the Cardiology Business digital magazine. More information on the IPPS proposed rule is available here.

 

 

Related Content on Intravascular Lithotripsy to Break Up Calcified Lesions:

VIDEO: Shockwave Medical demonstrates faster intravascular lithotripsy at ACC22

Shockwave’s IVL technology gains FDA approval for treating advanced coronary artery disease

Multicenter trial to evaluate IVL treatment for peripheral lesions below the knee

Better Together? An Integrated Market for Calcium-modification Strategies

IVL Turns Standard Balloon Technology into a Powerful Calcium-disruption Tool

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

Q&A: MedAxiom CEO explores key trends in cardiologist, cardiovascular surgeon compensation
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access
Abbott opens CGM sensor manufacturing facility in Ireland as part of $465M investment
Eko Health’s AI platform for digital stethoscopes granted new CPT code
Cardiologist demand is on the rise—can hospitals keep up?
Cardiologist receives 35 months in prison for health insurance fraud

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."